INFLIXIMAB (IFX) - ANVISA Registration 80102511760
Access comprehensive regulatory information for INFLIXIMAB (IFX) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102511760 and manufactured by BUHLMANN LABORATORIES AG. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 4 companies making the same product including IMMUNDIAGNOSTIK AG, PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80102511760
25351580029201604
04718143000194
Company Information
Dates and Status
Mar 27, 2017
VIGENTE
09/18/2025 19:00:01
ANTI-INFLIXIMAB (IFX) ANTIBODIES
Quantum Blue® Anti-Infliximab
Not specified
80102512585
Sep 24, 2020
IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS
IHQ
IMMUNOBIOSCIENCE CORP.
10039370003
Feb 10, 2014
IMMUNOGLOBULIN G
IgG MONO
KOVALENT DO BRASIL LTDA
80115310068
Aug 14, 2006
ANTI-INTRINSIC FACTOR ANTIBODY
ACCESS INTRINSIC FACTOR Ab QC
BECKMAN COULTER, INC.
10033120546
Jun 25, 2007
IMMUNOGLOBULIN G
ABX PENTRA IgG CP
HORIBA ABX SAS
10347320205
Nov 23, 2009
INFLIXIMAB (IFX)
IDKmonitor® Infliximab drug level ELISA
IMMUNDIAGNOSTIK AG
80464810919
May 05, 2025
INFLIXIMAB (IFX)
LISA-TRACKER INFLIXIMAB
BIOSYNEX SA
10338930321
Aug 05, 2024
INFLIXIMAB (IFX)
Família AFIAS Infliximab
BODITECH MED INC.
10350840426
Oct 20, 2022
INFLIXIMAB (IFX)
PROMONITOR IFX
PROGENIKA BIOPHARMA S.L.
80134860242
Jul 03, 2017